A U.S. Department of Health and Human Service COVID-19 Public Education Campaign to explain who is at increased risk for severe illness from COVID, the availability of COVID treatments, and the importance of early treatment.
IDSA releases updated recommendations on neutralizing antibodies as it relates to the newer omicron subvariants in the treatment of patients with COVID-19.
IDSA is pleased to announce that Roger J. Bedimo, MD, FIDSA, has been selected as the next editor-in-chief of Open Forum Infectious Diseases. Dr. Bedimo will succeed interim co-editors-in-chief John Baddley, MD, MSPH, and Andrej Spec, MD, MSCI, FIDSA, who have led OFID throughout the search process.
Loading...
We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.
